• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hara Tomoya  原 知也

ORCIDConnect your ORCID iD *help
… Alternative Names

原 知也  ハラ トモヤ

HARA Tomoya  原 知也

Less
Researcher Number 00644577
Affiliation (Current) 2025: 徳島大学, 病院, 助教
Affiliation (based on the past Project Information) *help 2023: 徳島大学, 病院, 助教
2016: 徳島大学, 病院, 医員
2014 – 2015: 徳島大学, 大学病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 53020:Cardiology-related / Cardiovascular medicine
Keywords
Principal Investigator
動脈硬化 / マクロファージ / 核酸受容体 / 慢性炎症 / 凝固 / 炎症 / 血液凝固因子 / 凝固因子
  • Research Projects

    (2 results)
  • Research Products

    (6 results)
  • Co-Researchers

    (2 People)
  •  DNase IIが血管の炎症と動脈硬化に与える影響の検討Principal Investigator

    • Principal Investigator
      原 知也
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53020:Cardiology-related
    • Research Institution
      The University of Tokushima
  •  Activated Factor X - Protease-Activated Receptors Signaling Promotes Vascular Inflammation and AtherosclerosisPrincipal Investigator

    • Principal Investigator
      HARA Tomoya
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Cardiovascular medicine
    • Research Institution
      The University of Tokushima

All 2016 2015 2014

All Journal Article Presentation

  • [Journal Article] Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.2015

    • Author(s)
      Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M.
    • Journal Title

      Atherosclerosis.

      Volume: 印刷中 Issue: 2 Pages: 639-646

    • DOI

      10.1016/j.atherosclerosis.2015.03.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25461131, KAKENHI-PROJECT-26860565, KAKENHI-PROJECT-25460369, KAKENHI-PROJECT-25293184
  • [Presentation] Critical Role in Bone Marrow Protease-Activated Receptor-2 in the Pathogenesis of Vascular Inflammation and Atherosclerosis in ApoE-Deficient Mice2016

    • Author(s)
      原知也
    • Organizer
      第80回日本循環器学会学術集会
    • Place of Presentation
      国際展示場(宮城県仙台市)
    • Year and Date
      2016-03-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26860565
  • [Presentation] Hematopoietic Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in ApoE-Deficient Mice2015

    • Author(s)
      Hara T
    • Organizer
      AHA Scientific Sessions 2015
    • Place of Presentation
      Orland, USA
    • Year and Date
      2015-11-09
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26860565
  • [Presentation] Rivaroxaban, a direct factor Xa inhibitor, attenuates neointima formation following vascular injury in the mouse through the inhibition of proliferative activation of vascular smooth muscle cells.2014

    • Author(s)
      Tomoya Hara, Daiju Fukuda, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Masataka Sata.
    • Organizer
      ESC Congress 2014
    • Place of Presentation
      Fira Barcelona Gran Via Conference Centre, Barcelona (Spain)
    • Year and Date
      2014-09-02
    • Data Source
      KAKENHI-PROJECT-26860565
  • [Presentation] Rivaroxaban, a direct factor Xa inhibitor, attenuates plaque progression and destabilization in ApoE-deficient mice by inhibiting macrophage activation.2014

    • Author(s)
      Tomoya Hara, Daiju Fukuda, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Masataka Sata.
    • Organizer
      ESC Congress 2014
    • Place of Presentation
      Fira Barcelona Gran Via Conference Centre, Barcelona (Spain)
    • Year and Date
      2014-09-01
    • Data Source
      KAKENHI-PROJECT-26860565
  • [Presentation] Rivaroxaban, a Direct Factor Xa Inhibitor, Attenuates Neointima Formation after Mechanical Vascular Injury2014

    • Author(s)
      Tomoya Hara, Daiju Fukuda, Kimie Tanaka, Yasutomi Higashikuni, Yoichiro Hirata, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Michio Shimabukuro, Masataka Sata.
    • Organizer
      The AHA 2014 Annual Membership Meeting
    • Place of Presentation
      McCormick Place, Chicago (U.S.A.)
    • Year and Date
      2014-11-17
    • Data Source
      KAKENHI-PROJECT-26860565
  • 1.  YAGI Shusuke
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 2.  佐田 政隆
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi